Topics

Articles

Analysis finds that while basic Part D coverage costs have decreased by 4%, mid- and high-tier plans have seen hikes of 4% and 21%, respectively. 

Report: Medicare Part D Premiums Rise an Average of 11% Nationwide 

Michael Christel is Group Managing Editor of Pharmaceutical Commerce, Pharmaceutical Executive, and Applied Clinical Trials. He can be reached at mchristel@mjhlifesciences.com.

With today's pharmacy landscape shaken by unprecedented and wider disruption to healthcare support and delivery, community and independent entities strive to remain an integral cog in the mix.

Community Pharmacies in Crisis: Navigating the Challenges and Closures

Are SDOHs associated with Medicare, Medicaid, and private insurer spending?

The Connection Between Social Determinants of Health and US Healthcare Expenditures

Videos

Albert Thigpen, co-founder, Talentwise Consulting, discusses the valuable buckets pertaining to the PBM space. 

Access Insights 2024: Pharmacy Benefit Management Trends

Albert Thigpen, co-founder, Talentwise Consulting, explains how to use these tactics in order to anticipate the future US healthcare policy environment.

Access Insights 2024: Reassessing Pricing and Commercialization Approaches

Albert Thigpen, co-founder, Talentwise Consulting, offers highlights of the drug commercialization panel that he participated in.

Access Insights 2024: Key Nuggets Surrounding the Chess Endgame

A panel dives into the current and future outlook of healthcare policies. 

Access Insights 2024: Playing the Chess Endgame 

Session dives into how healthcare policy implementation impacts stakeholders long-term.  

Access Insights 2024: Practicing Proactivity by Mapping Out Future Chessboard Moves

William Sarraille, professor, University of Maryland Francis King Carey School of Law, discusses other standout sessions at this year’s Access Insights conference.

Access Insights 2024: Notable Breakout Sessions

The session dives into the obstacles surrounding data usability, mandate compliance, initial adoption, and limitations in this arena. 

Market Access